Chikage Iguchi

490 total citations
22 papers, 376 citations indexed

About

Chikage Iguchi is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Chikage Iguchi has authored 22 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 6 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Chikage Iguchi's work include Pancreatic and Hepatic Oncology Research (5 papers), Breast Cancer Treatment Studies (5 papers) and Cancer-related Molecular Pathways (4 papers). Chikage Iguchi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Breast Cancer Treatment Studies (5 papers) and Cancer-related Molecular Pathways (4 papers). Chikage Iguchi collaborates with scholars based in Japan, Switzerland and Russia. Chikage Iguchi's co-authors include Yoshinori Nio, Kunihiro Yamasawa, Noriyuki Hirahara, Katsuhiro Tamura, Masayuki Itakura, Michio Takamura, Susumu Sasaki, Tomoko Toga, Ming Dong and Riruke Maruyama and has published in prestigious journals such as British Journal of Cancer, Journal of Surgical Oncology and Oncology Reports.

In The Last Decade

Chikage Iguchi

22 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chikage Iguchi Japan 12 236 139 81 78 69 22 376
Masataka Sasaki Japan 10 178 0.8× 65 0.5× 70 0.9× 114 1.5× 95 1.4× 24 387
Mileka Gilbert United States 6 192 0.8× 131 0.9× 90 1.1× 47 0.6× 50 0.7× 13 416
Miki Takenaka Japan 9 195 0.8× 121 0.9× 89 1.1× 73 0.9× 145 2.1× 22 410
Kunihiro Yamasawa Japan 12 288 1.2× 144 1.0× 72 0.9× 156 2.0× 94 1.4× 24 487
Shigeru Nanbara Japan 7 203 0.9× 77 0.6× 98 1.2× 121 1.6× 109 1.6× 16 453
Mohamed Mabed Egypt 12 93 0.4× 111 0.8× 46 0.6× 127 1.6× 37 0.5× 41 401
Benno Traub Germany 9 156 0.7× 86 0.6× 54 0.7× 126 1.6× 35 0.5× 20 307
Masayuki Itakura Japan 13 246 1.0× 56 0.4× 76 0.9× 141 1.8× 118 1.7× 47 474
Celestia Davis United States 9 84 0.4× 172 1.2× 44 0.5× 144 1.8× 69 1.0× 13 377
Sadanori Fuchimoto Japan 12 131 0.6× 89 0.6× 38 0.5× 79 1.0× 120 1.7× 59 400

Countries citing papers authored by Chikage Iguchi

Since Specialization
Citations

This map shows the geographic impact of Chikage Iguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chikage Iguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chikage Iguchi more than expected).

Fields of papers citing papers by Chikage Iguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chikage Iguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chikage Iguchi. The network helps show where Chikage Iguchi may publish in the future.

Co-authorship network of co-authors of Chikage Iguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Chikage Iguchi. A scholar is included among the top collaborators of Chikage Iguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chikage Iguchi. Chikage Iguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujita, Noriko, Chikage Iguchi, Yoshimasa Miyagawa, et al.. (2024). Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report. Journal of Medical Case Reports. 18(1). 214–214. 1 indexed citations
2.
3.
Fujita, Noriko, Tetsu Yanagisawa, Chikage Iguchi, et al.. (2019). Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab. Oncology. 98(1). 35–41. 6 indexed citations
4.
Iguchi, Chikage, et al.. (2011). TWO CASES OF APPENDICOLITHIASIS AND THE CHEMICAL COMPOSITIONS OF APPENDICEAL CALCULI. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72(9). 2302–2306. 1 indexed citations
5.
Nio, Yoshinori, et al.. (2010). Ductal carcinoma in situ arising within a benign phyllodes tumor: A case report with a review of the literature. Oncology Letters. 2(2). 223–228. 21 indexed citations
6.
Nio, Yoshinori, Chikage Iguchi, Masayuki Itakura, et al.. (2009). Placement of an expandable metallic stent improves the efficacy of chemoradiotherapy for pancreatic cancer with malignant portal vein stenosis or obstruction.. PubMed. 29(8). 3329–35. 10 indexed citations
7.
Nio, Yoshinori, Chikage Iguchi, Masayuki Itakura, et al.. (2009). High incidence of synchronous or metachronous breast cancer in patients with malignant and benign thyroid tumor or tumor-like disorders.. PubMed. 29(5). 1607–10. 13 indexed citations
8.
Nio, Yoshinori, Chikage Iguchi, Masayuki Itakura, et al.. (2007). Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase. Oncology Reports. 17(1). 153–9. 7 indexed citations
9.
Kodama, Hiroshi, Yoshinori Nio, Chikage Iguchi, & Norimichi Kan. (2006). Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer. British Journal of Cancer. 95(7). 811–816. 19 indexed citations
10.
11.
Hirahara, Noriyuki, Yoshinori Nio, Susumu Sasaki, et al.. (2001). Inoculation of Human Interleukin-17 Gene-Transfected Meth-A Fibrosarcoma Cells Induces T Cell-Dependent Tumor-Specific Immunity in Mice. Oncology. 61(1). 79–89. 95 indexed citations
12.
Nio, Yoshinori, Ming Dong, Chikage Iguchi, et al.. (2001). Expression of Bcl‐2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: Effects on clinical outcome and efficacy of adjuvant chemotherapy. Journal of Surgical Oncology. 76(3). 188–196. 32 indexed citations
13.
Nio, Yoshinori, Chikage Iguchi, Kunihiro Yamasawa, et al.. (2001). Apoptosis and Expression of Bcl-2 and Bax Proteins in Invasive Ductal Carcinoma of the Pancreas. Pancreas. 22(3). 230–239. 24 indexed citations
14.
Hirahara, Noriyuki, Yoshinori Nio, Susumu Sasaki, et al.. (2000). Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene.. PubMed. 20(5A). 3137–42. 23 indexed citations
15.
Hirahara, Noriyuki, et al.. (2000). Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.. PubMed. 20(5A). 3293–9. 24 indexed citations
16.
Nio, Yoshinori, Chikage Iguchi, Kunihiro Yamasawa, et al.. (1999). Oral UFT (uracil plus futrafur) for neoadjuvant chemotherapy of gastric cancer. Gastric Cancer. 2(1). 64–73. 1 indexed citations
17.
Nio, Yoshinori, Ming Dong, Noriyuki Hirahara, et al.. (1999). Comparative Significance of p53 and WAF/l-p2 1 Expression on the Efficacy of Adjuvant Chemotherapy for Resectable Invasive Ductal Carcinoma of the Pancreas. Pancreas. 18(2). 117–126. 24 indexed citations
18.
Iguchi, Chikage, Yuji Sato, Hideto Watanabe, et al.. (1999). [A case of recurrent ampullary carcinoma of the papilla of Vater, in which a complete response was induced by combination therapy using radiotherapy and oral chemotherapy employing UFT and cyclophosphamide].. PubMed. 26(11). 1641–5. 2 indexed citations
19.
Nio, Yoshinori, Ming Dong, Noriyuki Hirahara, et al.. (1999). p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas.. PubMed. 18(5B). 3773–9. 14 indexed citations
20.
Hirahara, Noriyuki, et al.. (1998). A case of multiple juvenile papillomatosis of the breast and its immunohistochemical pathology. Breast Cancer. 5(2). 187–193. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masataka Sasaki Breakdown of academic impact, for papers by Mileka Gilbert Breakdown of academic impact, for papers by Miki Takenaka Breakdown of academic impact, for papers by Kunihiro Yamasawa Breakdown of academic impact, for papers by Shigeru Nanbara Breakdown of academic impact, for papers by Mohamed Mabed Breakdown of academic impact, for papers by Benno Traub Breakdown of academic impact, for papers by Masayuki Itakura Breakdown of academic impact, for papers by Celestia Davis Breakdown of academic impact, for papers by Sadanori Fuchimoto
Rankless by CCL
2026